Drug that targets an inflammatory enzyme could help prevent lung cancer
4 Articles
4 Articles
Up to 71 percent of patients achieved clear or almost clear skin – here's who the new therapy is forA new drug, icotrokinra, could bring a significant change in the treatment of moderate to severe plaque psoriasis. Unlike biological therapies that act on the same inflammatory pathway, but are given by injection, this drug is taken orally and acts directly on the interleukin 23 receptor.The European Medicines Agency (EMA) has recommended its appr…
Drug that targets an inflammatory enzyme could help prevent lung cancer
MIT researchers showed that blocking caspase-1, an enzyme involved in lung inflammation, appears to reduce the risk of developing tumors. The enzyme-blocking drug might help prevent lung cancer in people at high risk for the disease.
Caspase-1 Inhibition Shows Promise as a New Strategy to Prevent Lung Cancer
Researchers at MIT have identified a potential new approach to reducing lung cancer risk by targeting caspase-1, an enzyme involved in inflammation. Findings published in Science Advances suggest that blocking this enzyme may suppress tumor formation before cancer becomes established, opening the door to a new category of preventive therapies for individuals at elevated risk. […]
A New Way to Stop Lung Cancer Before It Starts
Lung cancer remains one of the deadliest cancers in the world. Smoking is its biggest cause, but people who have never smoked can also develop the disease because of factors such as air pollution, secondhand smoke, workplace exposures, genetics, and other changes in the lungs. Scientists at MIT are now exploring an unusual way to […] The post A New Way to Stop Lung Cancer Before It Starts appeared first on Knowridge Science Report.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
